Article
Connection domain mutations in treatment-experienced patients in the OPTIMA trial.
Journal of acquired immune deficiency syndromes (1999) - 1 Jun 2010
Dau Birgitt, Ayers Dieter, Singer Joel, Harrigan P Richard, Brown Sheldon, Kyriakides Tassos, Cameron D William, Angus Brian, Holodniy Mark
Abstract excerpt
OBJECTIVES: To determine the frequency of mutations in the connection domain (CD) of HIV reverse transcriptase in treatment-experienced patients in the Options in Management with Antiretrovirals trial, their impact on susceptibility to antiretroviral (ARV) drugs, and their impact on virologic outcomes. METHODS: Baseline plasma ARV genotypes and inferred resistance phenotypes were obtained. Frequencies of E312Q,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
